What Researchers Did
Researchers retrospectively compared vascular endothelial function in 115 patients undergoing coronary stent implantation, with 55 receiving hyperbaric oxygen therapy and 60 serving as controls.
What They Found
After treatment, patients in the hyperbaric oxygen group showed significantly higher levels of flow-mediated dilation (FMD), nitric oxide (NO), and calcitonin gene-related peptide (CGRP) compared to the control group (p<0.05). Conversely, high-sensitivity C-reactive protein (hs-CRP) and endothelin-1 (ET-1) levels were significantly lower in the hyperbaric oxygen group than in controls (p<0.05).
What This Means for Canadian Patients
For Canadian patients undergoing coronary stent implantation, adjunctive hyperbaric oxygen therapy may offer a potential benefit by improving vascular endothelial function. This could lead to better long-term outcomes by reducing inflammation and improving blood vessel health after the procedure.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or participants.
Study Limitations
A primary limitation of this study is its retrospective design, which may introduce selection bias and limit the generalizability of the findings.